References
- Horiuchi, T.; Mitoma, H.; Harashima, S.; Tsukamoto, H.; Shimoda, T. Transmembrane TNF-Alpha: Structure, Function and Interaction with Anti-TNF Agents. Rheumatology 2010, 49, 1215–1228. DOI: https://doi.org/10.1093/rheumatology/keq031.
- Mitoma, H.; Horiuchi, T.; Tsukamoto, H.; Tamimoto, Y.; Kimoto, Y.; Uchino, A.; To, K.; Harashima, S.; Hatta, N.; Harada, M. Mechanisms for Cytotoxic Effects of Anti-Tumor Necrosis Factor Agents on Transmembrane Tumor Necrosis Factor Alpha-Expressing Cells: Comparison Among Infliximab, Etanercept, and Adalimumab. Arthritis Rheum. 2008, 58, 1248–1257. DOI: https://doi.org/10.1002/art.23447.
- Furst, D. E.; Keystone, E. C.; So, A. K.; Braun, J.; Breedveld, F. C.; Burmester, G. R.; De Benedetti, F.; Dörner, T.; Emery, P.; Fleischmann, R.; et al. Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic diseases, 2012. Ann. Rheum. Dis. 2013, 72, ii2–ii34. DOI: https://doi.org/10.1136/annrheumdis-2013-203348.
- Nesbitt, A.; Fossati, G.; Bergin, M.; Stephens, P.; Stephens, S.; Foulkes, R.; Brown, D.; Robinson, M.; Bourne, T. Mechanism of Action of Certolizumab Pegol (CDP870): In Vitro Comparison with Other anti-Tumor Necrosis Factor Alpha Agents. Inflamm. Bowel Dis. 2007, 13, 1323–1332. DOI: https://doi.org/10.1002/ibd.20225.
- Arora, T.; Padaki, R.; Liu, L.; Hamburger, A. E.; Ellison, A. R.; Stevens, S. R.; Louie, J. S.; Kohno, T. Differences in Binding and Effector Functions between Classes of TNF Antagonists. Cytokine 2009, 45, 124–131. DOI: https://doi.org/10.1016/j.cyto.2008.11.008.
- Kaymakcalan, Z.; Sakorafas, P.; Bose, S.; Scesney, S.; Xiong, L.; Hanzatian, D. K.; Salfeld, J.; Sasso, E. H. Comparisons of Affinities, Avidities, and Complement Activation of Adalimumab, Infliximab, and Etanercept in Binding to Soluble and Membrane Tumor Necrosis Factor. Clin. Immunol. 2009, 131, 308–316. DOI: https://doi.org/10.1016/j.clim.2009.01.002.
- Scott, D. L.; Kingsley, G. H. Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis. N. Engl. J. Med. 2006, 355, 704–712. DOI: https://doi.org/10.1056/NEJMct055183.
- Rita Costa, A.; Elisa Rodrigues, M.; Henriques, M.; Azeredo, J.; Oliveira, R. Guidelines to Cell Engineering for Monoclonal Antibody Production. Eur. J. Pharm. Biopharm. 2010, 74, 127–138. DOI: https://doi.org/10.1016/j.ejpb.2009.10.002.
- Wurm, F. M. Production of Recombinant Protein Therapeutics in Cultivated Mammalian Cells. Nat. Biotechnol. 2004, 22, 1393–1398. DOI: https://doi.org/10.1038/nbt1026.
- Kim, J. Y.; Kim, Y. G.; Lee, G. M. CHO Cells in Biotechnology for Production of Recombinant Proteins: Current State and Further Potential. Appl. Microbiol. Biotechnol. 2012, 93, 917–930. DOI: https://doi.org/10.1007/s00253-011-3758-5.
- Derouazi, M.; Martinet, D.; Besuchet Schmutz, N.; Flaction, R.; Wicht, M.; Bertschinger, M.; Hacker, D. L.; Beckmann, J. S.; Wurm, F. M. Genetic Characterization of CHO Production Host DG44 and Derivative Recombinant Cell Lines. Biochem. Biophys. Res. Commun. 2006, 340, 1069–1077. DOI: https://doi.org/10.1016/j.bbrc.2005.12.111.
- Florian, F. M.; Hacker, D. First CHO Genome. Nat. Biotechnol. 2011, 29, 718–720. DOI: https://doi.org/10.1038/nbt.1943.
- Betts, Z.; Croxford, A. S.; Dickson, A. J. Evaluating the Interaction between UCOE and DHFR-Linked Amplification and Stability of Recombinant Protein Expression. Biotechnol. Prog. 2015, 31, 1014–1025. DOI: https://doi.org/10.1002/btpr.2083.
- Benton, T.; Chen, T.; McEntee, M.; Fox, B.; King, D.; Crombie, R.; Thomas, T. C.; Bebbington, C. The Use of UCOE Vectors in Combination with a Preadapted Serum Free, Suspension Cell Line Allows for Rapid Production of Large Quantities of Protein. Cytotechnology 2002, 38, 43–46. DOI: https://doi.org/10.1023/A:1021141712344.
- Chusainow, J.; Yang, Y. S.; Yeo, J. H.; Toh, P. C.; Asvadi, P.; Wong, N. S.; Yap, M. G. A Study of Monoclonal Antibody-Producing CHO Cell Lines: What Makes a Stable High Producer? Biotechnol. Bioeng. 2009, 102, 1182–1196. DOI: https://doi.org/10.1002/bit.22158.
- Song, S. W.; Lee, S. J.; Kim, C. Y.; Han, B.; Oh, J. W. Rapid Establishment of CHO Cell Lines Producing the anti-Hepatocyte Growth Factor Antibody SFN68. J. Microbiol. Biotechnol. 2013, 23, 1176–1184. DOI: https://doi.org/10.4014/jmb.1305.05056.
- Majocchi, S.; Aritonovska, E.; Mermod, N. Epigenetic Regulatory Elements Associate with Specific Histone Modifications to Prevent Silencing of Telomeric Genes. Nucleic Acids Res. 2014, 42, 193–204. DOI: https://doi.org/10.1093/nar/gkt880.
- Saunders, F.; Sweeney, B.; Antoniou, M. N.; Stephens, P.; Cain, K. Chromatin Function Modifying Elements in an Industrial Antibody Production Platform-Comparison of UCOE, MAR, STAR and cHS4 Elements. PLoS One. 2015, 10, e0120096. DOI: https://doi.org/10.1371/journal.pone.0120096.
- Romanova, N.; Noll, T. Engineered and Natural Promoters and Chromatin-Modifying Elements for Recombinant Protein Expression in CHO Cells. Biotechnol. J. 2018, 13, e1700232. DOI: https://doi.org/10.1002/biot.201700232.
- Guo, X.; Wang, C.; Wang, T. Y. Chromatin-Modifying Elements for Recombinant Protein Production in Mammalian Cell Systems. Crit. Rev. Biotechnol. 2020, 40, 1035–1043. DOI: https://doi.org/10.1080/07388551.2020.1805401.
- Zhang, F.; Frost, A. R.; Blundell, M. P.; Bales, O.; Antoniou, M. N.; Thrasher, A. J. A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation-Mediated Silencing of Lentiviral Vectors. Mol. Ther. 2010, 18, 1640–1649. DOI: https://doi.org/10.1038/mt.2010.132.
- Boscolo, S.; Mion, F.; Licciulli, M.; Macor, P.; De Maso, L.; Brce, M.; Antoniou, M. N.; Marzari, R.; Santoro, C.; Sblattero, D. Simple Scale-up of Recombinant Antibody Production Using an UCOE Containing Vector. N Biotechnol. 2012, 29, 477–484. DOI: https://doi.org/10.1016/j.nbt.2011.12.005.
- Betts, Z.; Dickson, A. J. Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells. Mol. Biotechnol. 2015, 57, 846–858. DOI: https://doi.org/10.1007/s12033-015-9877-y.
- Hoseinpoor, R.; Kazemi, B.; Rajabibazl, M.; Rahimpour, A. Improving the Expression of anti-IL-2Rα Monoclonal Antibody in the CHO Cells through Optimization of the Expression Vector and Translation Efficiency. J. Biotechnol. 2020, 324, 112–120. DOI: https://doi.org/10.1016/j.jbiotec.2020.09.006.
- Nematpour, F.; Mahboudi, F.; Vaziri, B.; Khalaj, V.; Ahmadi, S.; Ahmadi, M.; Ebadat, S.; Davami, F. Evaluating the Expression Profile and Stability of Different UCOE Containing Vector Combinations in mAb-Producing CHO Cells. BMC Biotechnol. 2017, 17, 18. DOI: https://doi.org/10.1186/s12896-017-0330-0.
- Xiong, K. H.; Liang, Q. C.; Xiong, H.; Zou, C. X.; Gao, G. D.; Zhao, Z. W.; Zhang, H. Expression of Chimeric Antibody in Mammalian Cells Using Dicistronic Expression vector. Biotechnol. Lett. 2005, 27, 1713–1717. DOI: https://doi.org/10.1007/s10529-005-2736-3.
- Ng, S. K.; Wang, D. I.; Yap, M. G. Application of Destabilizing Sequences on Selection Marker for Improved Recombinant Protein Productivity in CHO-DG44. Metab. Eng. 2007, 9, 304–316. DOI: https://doi.org/10.1016/j.ymben.2007.01.001.
- Akbarzadeh-Sharbaf, S.; Yakhchali, B.; Minuchehr, Z.; Shokrgozar, M. A.; Zeinali, S. Expression Enhancement in Trastuzumab Therapeutic Monoclonal Antibody Production Using Genomic Amplification with Methotrexate. Avicenna J. Med. Biotechnol. 2013, 5, 87–95.
- Balabashin, D.; Kovalenko, E.; Toporova, V.; Aliev, T.; Panina, A.; Svirshchevskaya, E.; Dolgikh, D.; Kirpichnikov, M. Production of anti TNF-α Antibodies in Eukaryotic Cells Using Different Combinations of Vectors Carrying Heavy and Light Chains. Cytotechnology 2015, 67, 761–772. DOI: https://doi.org/10.1007/s10616-014-9714-3.
- Zhang, H.; Wang, H.; Liu, M.; Zhang, T.; Zhang, J.; Wang, X.; Xiang, W. Rational Development of a Serum-Free Medium and Fed-Batch Process for a GS-CHO Cell Line Expressing Recombinant Antibody. Cytotechnology 2013, 65, 363–378. DOI: https://doi.org/10.1007/s10616-012-9488-4.
- Blondeel, E. J. M.; Ho, R.; Schulze, S.; Sokolenko, S.; Guillemette, S. R.; Slivac, I.; Durocher, Y.; Guillemette, J. G.; McConkey, B. J.; Chang, D.; et al. An Omics Approach to Rational Feed: Enhancing Growth in CHO Cultures with NMR Metabolomics and 2D-DIGE Proteomics. J. Biotechnol. 2016, 234, 127–138. DOI: https://doi.org/10.1016/j.jbiotec.2016.07.027.
- Lu, F.; Toh, P. C.; Burnett, I.; Li, F.; Hudson, T.; Amanullah, A.; Li, J. Automated Dynamic Fed-Batch Process and Media Optimization for High Productivity Cell Culture Process Development. Biotechnol. Bioeng. 2013, 110, 191–205. DOI: https://doi.org/10.1002/bit.24602.
- Miki, H.; Takagi, M. Design of Serum-Free Medium for Suspension Culture of CHO Cells on the Basis of General Commercial Media. Cytotechnology 2015, 67, 689–697. DOI: https://doi.org/10.1007/s10616-014-9778-0.
- Li, W.; Fan, Z.; Lin, Y.; Wang, T. Y. Serum-Free Medium for Recombinant Protein Expression in Chinese Hamster Ovary Cells. Front. Bioeng. Biotechnol. 2021, 9, 646363. DOI: https://doi.org/10.3389/fbioe.2021.646363.
- Li, F.; Vijayasankaran, N.; Shen, A. Y.; Kiss, R.; Amanullah, A. Cell Culture Processes for Monoclonal Antibody Production. Mabs. 2010, 2, 466–479. DOI: https://doi.org/10.4161/mabs.2.5.12720.
- Kishishita, S.; Katayama, S.; Kodaira, K.; Takagi, Y.; Matsuda, H.; Okamoto, H.; Takuma, S.; Hirashima, C.; Aoyagi, H. Optimization of Chemically Defined Feed Media for Monoclonal Antibody Production in Chinese Hamster Ovary Cells. J. Biosci. Bioeng. 2015, 120, 78–84. DOI: https://doi.org/10.1016/j.jbiosc.2014.11.022.
- Yao, T.; Asayama, Y. Animal-Cell Culture Media: History, Characteristics, and Current Issues. Reprod. Med. Biol. 2017, 16, 99–117. DOI: https://doi.org/10.1002/rmb2.12024.
- Chun, B. H.; Kim, J. H.; Lee, H. J.; Chung, N. Usability of Size-Excluded Fractions of Soy Protein Hydrolysates for Growth and Viability of Chinese Hamster Ovary Cells in Protein-Free Suspension Culture. Bioresour. Technol. 2007, 98, 1000–1005.
- Kuwae, S.; Miyakawa, I.; Doi, T. Development of a Chemically Defined Platform Fed-Batch Culture Media for Monoclonal Antibody-Producing CHO Cell Lines with Optimized Choline Content. Cytotechnology 2018, 70, 939–948. DOI: https://doi.org/10.1007/s10616-017-0185-1.
- Reinhart, D.; Damjanovic, L.; Sommeregger, W. Influence of Cell Culture Media and Feed Supplements on Cell Metabolism and Quality of IgG Produced in CHO-K1; CHO-S; and CHO-DG44. BMC Proc. 2015, 9, P36. DOI: https://doi.org/10.1186/1753-6561-9-S9-P36.
- Torkashvand, F.; Vaziri, B.; Maleknia, S.; Heydari, A.; Vossoughi, M.; Davami, F.; Mahboudi, F. Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody. PLoS One. 2015, 10, e0140597. DOI: https://doi.org/10.1371/journal.pone.0140597.
- Pfaffl, M. W. A New Mathematical Model for Relative Quantification in Real-Time RT-PCR. Nucleic Acids Res. 2001, 29, e45. DOI: https://doi.org/10.1093/nar/29.9.e45.
- Sommeregger, W.; Prewein, B.; Reinhart, D.; Mader, A.; Kunert, R. Transgene Copy Number Comparison in Recombinant Mammalian Cell Lines: Critical Reflection of Quantitative real-time PCR Evaluation. Cytotechnology 2013, 65, 811–818. DOI: https://doi.org/10.1007/s10616-013-9606-y.
- Backliwal, G.; Hildinger, M.; Chenuet, S.; Wulhfard, S.; De Jesus, M.; Wurm, F. M. Rational Vector Design and Multi-Pathway Modulation of HEK 293E Cells Yield Recombinant Antibody Titers Exceeding 1 g/l by Transient Transfection Under Serum-Free Conditions. Nucleic Acids Res. 2008, 36, e96. DOI: https://doi.org/10.1093/nar/gkn423.
- Morrow, J. K. Optimizing Transient Gene Expression: Applications Expected to Move beyond Discovery and the Preclinical to Clinical Realm. Genet. Eng. Biotechnol. News 2008, 28, 54–59.
- Ye, J.; Alvin, K.; Latif, H.; Hsu, A.; Parikh, V.; Whitmer, T.; Tellers, M.; de la Cruz Edmonds, M. C.; Ly, J.; Salmon, P.; et al. Rapid Protein Production Using CHO Stable Transfection Pools. Biotechnol. Prog. 2010, 26, 1431–1437. DOI: https://doi.org/10.1002/btpr.469.
- Dharshanan, S.; Chong, H.; Cheah, S. H.; Zamrod, Z. Stable Expression of H1C2 Monoclonal Antibody in NS0 and CHO Cells Using pFUSE and UCOE Expression System. Cytotechnology 2014, 66, 625–633. DOI: https://doi.org/10.1007/s10616-013-9615-x.
- Otte, A. P.; Kwaks, T. H.; van Blokland, R. J.; Sewalt, R. G.; Verhees, J.; Klaren, V. N.; Siersma, T. K.; Korse, H. W.; Teunissen, N. C.; Botschuijver, S.; et al. Various Expression-Augmenting DNA Elements Benefit from STAR-Select, a Novel High Stringency Selection System for Protein Expression. Biotechnol. Prog. 2007, 23, 801–807. DOI: https://doi.org/10.1021/bp070107r.
- Omasa, T. Gene Amplification and Its Application in Cell and Tissue Engineering. J. Biosci. Bioeng. 2002, 94, 600–605. DOI: https://doi.org/10.1016/s1389-1723(02)80201-8.
- Tian, H.; Cronstein, B. N. Understanding the Mechanisms of Action of Methotrexate: Implications for the Treatment of Rheumatoid Arthritis. Bull. NYU Hosp. Jt. Dis. 2017, 65, 168–173.
- Huang, Y. M.; Hu, W.; Rustandi, E.; Chang, K.; Yusuf-Makagiansar, H.; Ryll, T. Maximizing Productivity of CHO Cell-Based Fed-Batch Culture Using Chemically Defined Media Conditions and Typical Manufacturing Equipment. Biotechnol. Prog. 2010, 26, 1400–1410. DOI: https://doi.org/10.1002/btpr.436.
- Sauer, P. W.; Burky, J. E.; Wesson, M. C.; Sternard, H. D.; Qu, L. A High-Yielding; Generic Fed-Batch Cell Culture Process for Production of Recombinant Antibodies. Biotechnol. Bioeng. 2000, 67, 585–597. DOI: https://doi.org/10.1002/(SICI)1097-0290(20000305)67:5<585::AID-BIT9>3.0.CO;2-H.